Literature DB >> 1174030

Chemico-pharmacological studies on saponins of Panax ginseng C. A. Meyer. I. Chemical part.

T Kaku, T Miyata, T Uruno, I Sako, A Kinoshita.   

Abstract

For the purpose of clarification of pharmacological actions of ginseng saponins we tried the isolation of ginseng saponins on a larger scale and succeeded in the isolation of eight saponins in a pure state and in sufficient amounts for the pharmacological assay. These eight saponins agreed all completely with the authentic samples of Shibata-Shoji and co-workers in molecular formula of saponins and sapogenins, sugars and TLC. The physical properties of saponins were shown. As other components of ginseng, there were isolated small amounts of panaxadiol, panaxatriol, daucosterol from the first running of column chromatography and mannitol, sucrose and glucose from the ethanol insoluble aqueous extract.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174030

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.

Authors:  Michung Yoon; Hyunghee Lee; Sunhyo Jeong; Jung-Jae Kim; Christopher J Nicol; Kung Woo Nam; Moonza Kim; Byung Goo Cho; Goo Taeg Oh
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

2.  American ginseng. III. Pharmacokinetics of ginsenosides in the rabbit.

Authors:  S E Chen; R J Sawchuk; E J Staba
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

3.  A trace component of ginseng that inhibits Ca2+ channels through a pertussis toxin-sensitive G protein.

Authors:  S Y Nah; H J Park; E W McCleskey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

4.  Comparing eight types of ginsenosides in ginseng of different plant ages and regions using RRLC-Q-TOF MS/MS.

Authors:  Yu-Lin Dai; Meng-Dan Qiao; Peng Yu; Fei Zheng; Hao Yue; Shu-Ying Liu
Journal:  J Ginseng Res       Date:  2017-11-08       Impact factor: 6.060

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.